Latest Cancer Stories
-- Data suggest presence of activated progesterone receptors in cells predict anti-progestin efficacy in endometrial and breast cancers; support further evaluation of onapristone FLEMINGTON, N.J., May 15, 2013 /PRNewswire/ -- Arno Therapeutics, Inc. (OTCQB: ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today announced new, positive data from three studies supporting its investigational compound onapristone to be presented at...
For U.S. Media Only RIDGEFIELD, Conn., May 15, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced the upcoming presentation of data from 14 abstracts involving three of the company's investigational oncology compounds - afatinib*, nintedanib* and volasertib*. Results - to be presented at the 49(th) Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 31-June 4, 2013 - are from Boehringer Ingelheim's robust...
CLEVELAND, May 15, 2013 /PRNewswire/ -- Researchers from University Hospitals Case Medical Center's (UHCMC) Seidman Cancer Center will present findings from two studies evaluating new technologies designed to address common barriers to patient enrollment in clinical trials. Results from a large-scale, randomized trial demonstrated that the use of tailored, web-based videos delivering educational information to patients before an oncologist visit can significantly improve knowledge and...
WAYNE, N.J., May 15, 2013 /PRNewswire/ -- Intended for U.S. Media Only -- Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) approved Xofigo(®) (radium Ra 223 dichloride) for the treatment of patients with castration-resistant prostate cancer (CRPC), symptomatic bone metastases and no known visceral metastatic disease. Xofigo is the first and only alpha particle-emitting radioactive therapeutic agent approved by the FDA that has demonstrated...
Interim Phase II Data and Follow-Up Analysis of Phase I Data Presented at Annual Meeting of the American Society of Gene and Cell Therapy DALLAS, May 15, 2013 /PRNewswire/ -- Today Gradalis, Inc. announced that FANG(TM), the company's tumor-based personalized cancer vaccine, elicits an immune response and delays time to recurrence in advanced stage ovarian cancer patients by more than one year compared to patients who received standard of care. Interim analysis of the Phase II...
GRAND PRAIRIE, Texas, May 15, 2013 /PRNewswire/ -- Rumble Against Cancer is a Nonprofit 501 c (3) Public Charity that promotes cancer research and the importance of it through motorcycle rides, rallies and other events. Proceeds generated by events and sales are donated directly to research programs and activities in support thereof. The Rumble Against Cancer National Tour will begin kickstands up at 9am August 15(th )2013. They will depart Longhorn Harley-Davidson in Grand Prairie,...
MANHATTAN BEACH, Calif., May 15, 2013 /PRNewswire/ -- A rigorous analysis of the Pancreatic Cancer Action Network research grants program has shown that the organization's grant recipients are leveraging their awards to secure impressive subsequent funding, publishing their findings, and enhancing knowledge about the disease. The organization evaluated their research grants program by looking at grants awarded from 2003-2011. During that time, 66 grants were awarded totaling $9.15...
LOS ANGELES, May 15, 2013 /PRNewswire/ -- Kite Pharma Inc. (Kite), a clinical stage biotechnology company focused on developing innovative targeted immunotherapies for cancer, today announced that it has closed a $20 million private placement of shares of its Series A Preferred Stock. In addition to the $20 million in new funds, Kite converted $15 million in outstanding promissory notes into shares of Series A Preferred Stock. Joined by a new investor, Alta Partners, all existing...
ATLANTA, May 15, 2013 /PRNewswire/ -- Galectin Therapeutics (NASDAQ: GALT) will host a conference call at 9:30 A.M. Eastern Time on Thursday, May 23, 2013, to provide an update following the Company's Annual Meeting of Shareholders. Additionally, Peter Traber, MD, President, CEO and CMO of Galectin Therapeutics, will update the investment community on the Company's pipeline of galectin inhibitor compounds and progress in its development of treatments for liver fibrosis and cancer....
HOUSTON, May 15, 2013 /PRNewswire/ -- ApoCell, Inc. announced that the first prototypes of its ApoStream(TM) circulating tumor cell (CTC) isolation system have been delivered to select investigator sites including SAIC-Frederick Inc. (SAIC-F) in support of the National Cancer Institute (NCI). The delivery is part of a $2.9 million subcontract awarded to ApoCell in Q1-2011 by SAIC-F to develop a device capable of isolating live cancer cells from small volumes of blood. While...
Latest Cancer Reference Libraries
The British Journal of Cancer (BJC) is a professional medical journal published biweekly by the Nature Publishing Group (a division of Macmillan Publishers Ltd.) on behalf of Cancer Research UK. It provides a forum for clinicians and scientists to communicate original research findings that have relevance to understanding the etiology of cancer and to improving patient treatment and survival. Papers are published both in print and online. The journal publishes full research papers and...
Merkel cell polyomavirus (MCV or MCPyV), first discovered in January 2008, is one of seven human tumor viruses. It is suspected to cause most of Merkel cell carcinoma which is a rare, aggressive form of skin cancer. Around 80% of Merkel cell carcinoma tumors are found to be infected with MCV. It is found in respiratory secretions suggesting that it may be transmitted by a respiratory route. Usually the tumors with MCV viruses go through at least two mutations that render the virus...
A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...
Asbestos (Greek a-, "not"; sbestos, "extinguishable") is a group of fibrous metamorphic minerals. The name is derived for its historical use in lamp wicks; the resistance of asbestos to fire has long been exploited for a variety of purposes. It was used in fabrics such as Egyptian burial cloths and Charlemagne's tablecloth, which, according to legend, he threw in a fire to clean. When asbestos is used for its resistance to fire or heat, the fibers are typically mixed with cement or woven...
Cancer Constellation -- The constellation Cancer, the crab, is known in astronomy and astrology as one of the twelve constellations of the zodiac. Cancer is small and dim, and does not resemble a crab. It lies between Gemini to the west and Leo to the east, Lynx to the north and Canis Minor and Hydra to the south. Notable features The brightest star in Cancer is β Cancri, called Al Tarf ("the end" of the crab's leg). Other stars include Acubens (α), and the Aselli (the...
